US68232V8019 - Common Stock
0.43 +0.02 (+5.52%)
After market: 0.43 0 (0%)
Differentiated resistance profile positions Traws’ program as a potential class leader
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update...